Skip to content

PEP-Hep Project

PEP-Hep: A Cluster Randomized Controlled Trial of a Prison Education Program to Improve Hepatitis B and C Testing Uptake and Treatment Initiation in Ghana.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202512558588684
Enrollment
368
Registered
2025-12-02
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B and Hepatitis C

Interventions

PEP Hep Prison Education Program to Improve Hepatitis B and C awareness testing and treatment.

Sponsors

University of Ghana Legon
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: • Male and female adult inmates (=18 years) who can legally provide informed consent • An inmate who has been incarcerated for 6 months and above • Inmates who are willing to provide informed consent

Exclusion criteria

Exclusion criteria: An inmate who is/has • Known to have documented chronic HBV or HCV infection prior to incarceration. • Currently undergoing treatment for HCV. • Severe cognitive impairment or mental health conditions that will hinder comprehension or informed consent. • Scheduled for transfer or release within 6 months of intervention start. • Transferred into prison after randomization. • Severe or uncontrolled psychiatric illness (e.g., active psychosis, schizophrenia, severe depression with suicidal ideation). • Acute or terminal medical condition (s) that will not allow full participation (e.g., critically ill, hospitalized, under palliative care). • Currently using medications known to interact with Direct-Acting Antivirals (DAAs).

Design outcomes

Primary

MeasureTime frame
The primary outcome of the PEP-Hep intervention is the uptake of hepatitis B and C testing among inmates following the four-week educational program. This reflects the central goal of the intervention, to improve awareness, increase motivation, and ultimately enhance participation in HBV and HCV testing services within the prison setting.

Secondary

MeasureTime frame
Secondary outcomes include improvements in hepatitis knowledge, testing intentions, and stigma reduction following the intervention. Additional secondary outcomes relate to the care cascade: the uptake of HCV treatment among those who test positive, HBV care linkage, and the proportion achieving HCV cure (SVR12/14) after treatment. Measures of participation in peer-led sessions and engagement with educational activities will further assess the feasibility and acceptability of the intervention.

Countries

Ghana

Contacts

Public ContactAugustina Ama Boadu

Director of Public Health Ghana Prisons

amawayo40@gmail.com233247583392

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026